Premenstrual dysphoric disorder: symptoms, causes and treatment
PMDD is a severe premenstrual condition with a strict timing pattern. Symptoms, causes, diagnosis and PMDD treatment options available in the UK.
Key points
- PMDD is a recognised diagnosis in DSM-5-TR and ICD-11, not a stronger word for premenstrual tension [7].
- The timing pattern is the key: symptoms appear in the luteal phase, the week or two before a period, and clear within days of bleeding starting [1][7].
- Diagnosis rests on daily symptom ratings kept across at least two cycles, not a one-off questionnaire [7][9].
- PMDD is often mistaken for bipolar disorder or borderline personality disorder, because all three involve rapid mood change [6][8].
- UK treatments include SSRIs, combined hormonal contraception and CBT, with hormone suppression and surgery kept for specialist services [1][5].
What premenstrual dysphoric disorder is
Premenstrual dysphoric disorder, usually shortened to PMDD, is a severe premenstrual condition causing marked mood and physical symptoms in the one to two weeks before a period, which ease within a few days of the period starting [1]. It is a recognised diagnosis in DSM-5-TR and in ICD-11, the World Health Organization’s current classification, which codes it under genitourinary conditions and cross-lists it with depressive disorders [7].
If you need help now. Samaritans: call 116 123, free, 24/7. Shout: text SHOUT to 85258. NHS 111, then choose the mental health option. Call 999 if anyone is in immediate danger.
About 40% of women report premenstrual symptoms, and around 5% to 8% have severe symptoms that interfere with daily life [4]. Estimates for PMDD itself are 3% to 4.1% in high income countries, with no reliable UK-only figure found [7]. PMDD affects anyone who has periods [1].
Symptoms
At least five symptoms are usually present, including at least one core mood symptom [7].
Core mood symptoms
- Rapid shifts in mood
- Irritability or anger, often at those closest
- Low mood, hopelessness or self-critical thinking
- Anxiety or tension
Other mental and behavioural symptoms
- Loss of interest in usual activities, or feeling overwhelmed by them
- Difficulty concentrating
- Low energy, or sleeping much more or much less than usual
- Change in appetite or food cravings
- Thoughts of suicide or self-harm in severe cases [1]
Physical symptoms
- Breast tenderness, bloating, joint or muscle pain, and headaches [1]
PMDD is commonly confused with premenstrual syndrome (PMS), depression, bipolar disorder and borderline personality disorder [6][8].
Types
PMDD has no recognised subtypes. It sits at the severe end of a group of premenstrual disorders, usually described as bands.
- PMS. Premenstrual symptoms ranging from mild, which do not stop someone working, to severe, which interfere with daily functioning [4].
- PMDD. The most severe form, defined by symptom count, marked distress or impairment, and a luteal timing pattern confirmed by daily records [9].
- Premenstrual exacerbation (PME). An existing condition, such as depression or bipolar disorder, present all month but worsening sharply before a period. In PMDD mental health is settled for the rest of the cycle; in PME symptoms never fully clear [8].
Causes and risk factors
There is no single cause. Evidence points to unusual sensitivity to normal hormone change rather than to abnormal hormone levels, which are typically in the usual range [1][9].
- Hormone sensitivity. Symptoms track the ovulatory cycle, and suppressing ovulation reduces them [5][9].
- Allopregnanolone and GABA. One line of research concerns allopregnanolone, a breakdown product of progesterone acting on GABA-A receptors in the brain, which may respond differently in PMDD. The evidence is still developing [9].
- Smoking, past trauma and family history. Each is linked to higher risk, mostly in observational studies that show association rather than cause [6][9].
Two popular explanations are not supported: PMDD is not a hormone imbalance a blood test can detect, and it is not poor coping or a difficult personality [9].
How it is diagnosed
Diagnosis usually starts with a GP, who may involve gynaecology, a psychiatrist or a specialist premenstrual clinic [6].
Assessment has two parts: a discussion of symptoms and their effect on work, study and relationships, then the part that decides it, prospective charting, meaning symptoms recorded daily as they happen across at least two consecutive cycles [5][7]. A validated chart, the Daily Record of Severity of Problems (DRSP), rates eleven symptoms each day [9].
Charting is required because recalled histories are unreliable, and because only a day by day record shows the pattern that defines PMDD: symptoms rising in the luteal phase, falling away within days of the period starting, then a symptom-free week [7]. A questionnaire filled in during a bad week cannot show that, and the same record separates PMDD from premenstrual exacerbation [8].
The record also settles the two diagnoses most often given instead. Bipolar disorder involves mood episodes lasting weeks that do not track the cycle. Borderline personality disorder involves a lasting pattern of unstable relationships and self-image present all month, not mood change confined to the luteal phase [7][8].
DSM-5-TR sets the criteria most clinicians use: at least five symptoms in most cycles over the past year, one a core mood symptom, with clear distress or impairment, confirmed by daily ratings over at least two symptomatic cycles [7][9]. A provisional diagnosis may be recorded while charting continues [7]. No reliable UK figure for waiting times to a specialist clinic was found.
Treatment
NICE publishes its advice on premenstrual disorders as a Clinical Knowledge Summary rather than as a numbered guideline, so UK practice also draws on Royal College of Obstetricians and Gynaecologists Green-top Guideline No. 48 [3][4]. Treatment moves through steps, least invasive first.
- Lifestyle measures. Regular exercise and sleep, less alcohol and caffeine, stopping smoking. Evidence is limited [5][6].
- Cognitive behavioural therapy (CBT). Recommended for the mood symptoms, alongside or instead of medication [5][6].
- SSRIs. Antidepressants used as a first-line medical treatment, taken either continuously through the cycle or only during the luteal phase. A 2024 Cochrane review of 34 trials found SSRIs probably reduce premenstrual symptoms compared with placebo, on moderate-certainty evidence. Continuous dosing through the cycle was probably more effective than luteal-phase-only dosing. Adverse effects including nausea, insomnia, sexual dysfunction and fatigue were more common than with placebo [10].
- Combined hormonal contraception. Combined pills, particularly those containing drospirenone, suppress ovulation. Evidence in PMDD specifically is mixed [5][6].
- GnRH analogues. Injections that switch off ovulation, used by specialist services and normally with add-back hormone treatment because of effects on bone density [5][6].
- Surgery. Removal of the ovaries, with or without the womb, is an irreversible last resort in very severe cases, and specialist-only [5][6].
Calcium, vitamin D and agnus castus are discussed in RCOG guidance as options some women find helpful, though the evidence is limited and they are not first-line treatments. Vitamin B6 is widely sold; speak to a GP or pharmacist before taking high doses [5][6].
Living with premenstrual dysphoric disorder
Keeping a daily symptom chart is the most useful thing you can do before a GP appointment. Two full cycles of dated records showing symptoms appearing and clearing is the evidence a clinician needs, and it is often what moves a consultation from low mood in general to premenstrual disorders in particular [5][7]. The National Association for Premenstrual Syndromes, a UK charity, publishes a free menstrual diary [2].
Tracking lets you see difficult days coming, so demanding tasks can be moved out of the luteal week [6].
At work or university you do not have to give a diagnosis to ask for adjustments; occupational health or student support can help arrange them. In England you can refer yourself to NHS Talking Therapies for anxiety and depression [6].
When to speak to a professional
Speak to your GP if premenstrual symptoms interfere with your work, studies or relationships. Take your symptom charts.
Contact your GP sooner if:
- Symptoms follow a clear monthly pattern and have persisted for at least two cycles [1]
- You have a mental health diagnosis that does not fit the cyclical timing of your symptoms
- You are treated for depression or bipolar disorder and symptoms worsen sharply before every period
Get help immediately, using the crisis contacts above, if you have thoughts of suicide or self-harm at any point in the cycle. That needs urgent attention, not waiting for the period to start [1].
Common questions
What is the difference between PMDD and PMS?
Both follow the menstrual cycle, but PMDD is defined by strict criteria: at least five symptoms including a core mood symptom, marked distress or impairment, and the timing pattern confirmed by daily records [7]. PMS covers a broader range of symptoms, mostly mild [4].
Can PMDD be mistaken for bipolar disorder?
Yes, and it often is. Weeks of stability followed by days of severe irritability and low mood can sound like rapid cycling bipolar disorder [6]. Daily charting separates them: PMDD mood change is locked to the luteal phase and clears with menstruation, while bipolar episodes do not follow the cycle. The two can also occur together [7].
Does PMDD stop after the menopause?
Premenstrual symptoms are tied to ovulatory cycles, so they stop when ovulation stops, including after the menopause. That is also why treatments that suppress ovulation reduce symptoms [5][6].
Clinical review pending
References
- NHS. PMDD (premenstrual dysphoric disorder). NHS. https://www.nhs.uk/conditions/pmdd-premenstrual-dysphoric-disorder/
- National Association for Premenstrual Syndromes. Menstrual Diary. NAPS. https://www.pms.org.uk/support/menstrual-diary/
- National Institute for Health and Care Excellence. Premenstrual syndrome: Supporting evidence. Clinical Knowledge Summaries. https://cks.nice.org.uk/topics/premenstrual-syndrome/supporting-evidence/
- Royal College of Obstetricians and Gynaecologists. Management of Premenstrual Syndrome (Green-top Guideline No. 48), second edition. BJOG 2017;124(3):e73 to e105; published November 2016, reviewed by the RCOG Guidelines Committee May 2023, update in development. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/premenstrual-syndrome-management-green-top-guideline-no-48/
- Royal College of Obstetricians and Gynaecologists. Managing premenstrual syndrome (PMS): patient information leaflet. RCOG. https://www.rcog.org.uk/for-the-public/browse-our-patient-information/managing-premenstrual-syndrome-pms-patient-information-leaflet/
- Mind. PMDD diagnosis, and Treatment for PMDD. Mind. https://www.mind.org.uk/information-support/types-of-mental-health-problems/premenstrual-dysphoric-disorder-pmdd/getting-a-pmdd-diagnosis/ and https://www.mind.org.uk/information-support/types-of-mental-health-problems/premenstrual-dysphoric-disorder-pmdd/treatment-for-pmdd/
- Naik SS, Yadav N, Kumar K, Grover S. Diagnostic validity of premenstrual dysphoric disorder: revisited. Frontiers in Global Women’s Health, 4:1181583, 2023. https://doi.org/10.3389/fgwh.2023.1181583
- Kulkarni J, Mu E. Premenstrual exacerbation of psychiatric symptoms: from misdiagnosis to management. The British Journal of Psychiatry, 226(6), 2025. https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/premenstrual-exacerbation-of-psychiatric-symptoms-from-misdiagnosis-to-management/CC16313FFBF61D5B78B3B6D557187B6D
- Mishra S, Elliott H, Marwaha R. Premenstrual Dysphoric Disorder. StatPearls, NCBI Bookshelf. StatPearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK532307/
- Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews, 2024, Issue 8, CD001396. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001396.pub4/full
